An Increase in MPC-1 - and MPC-1 - CD45 + Immature Myeloma Cells in the Progressive States of Bone Marrow Plasmacytosis: The Revised Phenotypic Classification of Monoclonal Marrow Plasmacytosis (MOMP-2005)-Reference-Cited by-同舟云学术

An Increase in MPC-1 - and MPC-1 - CD45 + Immature Myeloma Cells in the Progressive States of Bone Marrow Plasmacytosis: The Revised Phenotypic Classification of Monoclonal Marrow Plasmacytosis (MOMP-2005)

Published:2006-01-01 Issue:1 Volume:83 Page:39-43
ISSN:0925-5710
Container-title:International Journal of Hematology
language:
Short-container-title:International Journal of Hematology

Author:

Otsuyama Ken-ichiro,Asaoku Hideki,Kawano Michio M.

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://www.springerlink.com/index/pdf/10.1532/IJH97.05112

Reference16 articles.

1. Zhan F, Hardin J, Kordsmeier B, et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood. 2002;99:1745-1757.

2. Tarte K, De Vos J, Thykjaer T, et al. Generation of polyclonal plas-mablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts. Blood. 2002;100:1113-1122.

3. Terstappen LW, Johnson S, Segers-Nolten IM, Loken MR. Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry. Blood. 1990;76: 1739-1747.

4. Harada H, Kawano MM, Huang N, et al. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood. 1993;81: 2658-2663.

5. Kawano MM, Huang N, Harada H, et al. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood. 1993;82:564-570.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study;PLOS ONE;2021-07-09

2. Clinical effect of immunophenotyping on the prognosis of multiple myeloma patients treated with bortezomib;Oncology Letters;2017-03-27

3. Plasma cell maturity as a predictor of prognosis in multiple myeloma;Medical Oncology;2016-07-06

4. Unfolded protein response inducers tunicamycin and dithiothreitol promote myeloma cell differentiation mediated by XBP-1;Clinical and Experimental Medicine;2013-12-20

5. Plasma cell leukemia producing monoclonal immunoglobulin E;International Journal of Hematology;2009-08-29